Terms: = Ovarian cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Clinical Outcome
8 results:
1. Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Dall G; Vandenberg CJ; Nesic K; Ratnayake G; Zhu W; Vissers JHA; Bedő J; Penington J; Wakefield MJ; Kee D; Carmagnac A; Lim R; Shield-Artin K; Milesi B; Lobley A; Kyran EL; O'Grady E; Tram J; Zhou W; Nugawela D; Stewart KP; Caldwell R; Papadopoulos L; Ng AP; Dobrovic A; Fox SB; McNally O; Power JD; Meniawy T; Tan TH; Collins IM; Klein O; Barnett S; Olesen I; Hamilton A; Hofmann O; Grimmond S; Papenfuss AT; Scott CL; Barker HE
J Exp Clin Cancer Res; 2023 May; 42(1):112. PubMed ID: 37143137
[TBL] [Abstract] [Full Text] [Related]
2. Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer.
Dietze R; Hammoud MK; Gómez-Serrano M; Unger A; Bieringer T; Finkernagel F; Sokol AM; Nist A; Stiewe T; Reinartz S; Ponath V; Preußer C; von Strandmann EP; Müller-Brüsselbach S; Graumann J; Müller R
Theranostics; 2021; 11(3):1377-1395. PubMed ID: 33391540
[TBL] [Abstract] [Full Text] [Related]
3. Vacuum-assisted breast biopsies (VAB) carried out on an open 1.0T MR imager: Influence of patient and target characteristics on the procedural and clinical results.
Krug B; Hellmich M; Ulhaas A; Krämer S; Rhiem K; Zarghooni V; Püsken M; Schwabe H; Grinstein O; Markiefka B; Maintz D
Eur J Radiol; 2016 Jun; 85(6):1157-66. PubMed ID: 27161066
[TBL] [Abstract] [Full Text] [Related]
4. Impact of robotics on the outcome of elderly patients with endometrial cancer.
Lavoue V; Zeng X; Lau S; Press JZ; Abitbol J; Gotlieb R; How J; Wang Y; Gotlieb WH
Gynecol Oncol; 2014 Jun; 133(3):556-62. PubMed ID: 24708920
[TBL] [Abstract] [Full Text] [Related]
5. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
[TBL] [Abstract] [Full Text] [Related]
6. ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
Johnatty SE; Beesley J; Paul J; Fereday S; Spurdle AB; Webb PM; Byth K; Marsh S; McLeod H; ; Harnett PR; Brown R; DeFazio A; Chenevix-Trench G
Clin Cancer Res; 2008 Sep; 14(17):5594-601. PubMed ID: 18765553
[TBL] [Abstract] [Full Text] [Related]
7. Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
Hussain MM; Kotz H; Minasian L; Premkumar A; Sarosy G; Reed E; Zhai S; Steinberg SM; Raggio M; Oliver VK; Figg WD; Kohn EC
J Clin Oncol; 2003 Dec; 21(23):4356-63. PubMed ID: 14645425
[TBL] [Abstract] [Full Text] [Related]
8. Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon.
Silver HK; Connors JM; Kong S; Karim KA; Spinelli JJ
Br J Cancer; 1988 Dec; 58(6):783-7. PubMed ID: 2975951
[TBL] [Abstract] [Full Text] [Related]
